Canaccord Genuity Maintains Buy on Aspen Aerogels, Lowers Price Target to $10
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst George Gianarikas maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $11 to $10.
Canaccord Genuity analyst George Gianarikas maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $11 to $10.